Citigroup’s CHELSEA THERAPEUTICS INT'L LTD CHTP Stock Holding History

Citigroup’s Portfolio CHTP Stock Details CHTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-74	Closed	–	–	7618
2014 Q2	$0	Sell	74 -18,966	-100%	-$112K	﹤0.01%	7574
2014 Q1	$105K	Sell	19,040 -37,370	-66%	-$188K	﹤0.01%	4947
2013 Q4	$250K	Buy	56,410 +51,780	+1,118%	+$175K	﹤0.01%	4467
2013 Q3	$14K	Buy	4,630 +1,542	+50%	+$4.43K	﹤0.01%	6091
2013 Q2	$7K	Buy	+3,088	New	+$6.24K	﹤0.01%	6249

Citigroup's CHTP Position: Q3 2014 in Review

Citigroup sold out of CHELSEA THERAPEUTICS INT'L LTD (CHTP) in Q3 2014, closing a stake of 74 shares.

Citigroup first reported a position in CHTP in Q2 2013 and held it in 5 quarters. The position peaked at $250K in Q4 2013. 0 funds tracked by Wall St. Rank hold CHTP as of Q3 2014.

Citigroup reported no remaining CHELSEA THERAPEUTICS INT'L LTD position as of Q3 2014 after selling out during the quarter.
Citigroup sold 74 CHELSEA THERAPEUTICS INT'L LTD shares in Q3 2014.
Citigroup first reported a position in CHELSEA THERAPEUTICS INT'L LTD in Q2 2013 and held it in 5 quarters.
Citigroup's CHELSEA THERAPEUTICS INT'L LTD position peaked at $250K in Q4 2013.
0 funds tracked by Wall St. Rank held CHELSEA THERAPEUTICS INT'L LTD as of Q3 2014.

Based on Citigroup's 13F filing for Q3 2014, filed 14 Nov 2014.